Cannabis hyperemesis
Pro Research Analysisby 
Searched over 200M research papers for "cannabis hyperemesis"
Understanding Cannabis Hyperemesis Syndrome (CHS)
Introduction to Cannabis Hyperemesis Syndrome
Cannabis Hyperemesis Syndrome (CHS) is a condition characterized by cyclic episodes of nausea, vomiting, and abdominal pain in individuals who use cannabis chronically. Despite cannabis's well-known antiemetic properties, CHS presents a paradox where cannabis use leads to severe gastrointestinal distress 124.
Clinical Presentation and Diagnosis
Symptoms and Diagnostic Criteria
CHS typically affects young, chronic cannabis users and is marked by recurrent nausea, vomiting, and abdominal pain. A unique feature of CHS is the compulsive use of hot baths or showers to alleviate symptoms 126. Diagnosis is often challenging due to the paradoxical nature of cannabis's effects and the lack of strict diagnostic criteria 24.
Case Studies and Epidemiology
Several case studies have documented the syndrome across different populations. For instance, a study in France analyzed 29 cases and found that CHS predominantly affects young males who have been using cannabis daily for several years . Similarly, a U.S. study characterized eight cases, highlighting the recurrent nature of vomiting and the compulsive bathing behavior .
Pathophysiology and Hypotheses
Endocannabinoid System (ECS)
The exact pathophysiology of CHS remains unclear, but it is believed to involve the endocannabinoid system (ECS). The ECS plays a crucial role in regulating nausea and vomiting, and its dysregulation due to chronic cannabis use may lead to CHS . Cannabis's biphasic effect, where low doses act as antiemetics and high doses as pro-emetics, further complicates understanding 27.
Potential Triggers and Contributing Factors
Some researchers suggest that the quality of cannabis, including potential contamination with plant pathogens like hop latent viroid, could contribute to CHS. This pathogen can affect the cannabis plant's resin production, potentially leading to adverse effects in users .
Management and Treatment
Immediate and Long-term Management
The most effective treatment for CHS is the cessation of cannabis use. Studies have shown that symptoms often resolve completely with cannabis discontinuation 467. In acute settings, supportive care with intravenous fluids and antiemetics like haloperidol has shown some benefit. A clinical trial found haloperidol to be more effective than ondansetron in reducing nausea and abdominal pain .
Special Considerations in Palliative Care
In palliative care settings, CHS can present atypically due to the complexity of patients' medical conditions. Management may involve reducing rather than completely stopping cannabis use, especially when cannabis is used to manage other symptoms like pain and anxiety .
Conclusion
Cannabis Hyperemesis Syndrome is a complex and paradoxical condition associated with chronic cannabis use. Early recognition and cessation of cannabis are crucial for effective management. As cannabis use continues to rise globally, awareness and understanding of CHS among healthcare providers are essential to improve patient outcomes and reduce healthcare burdens 247. Further research is needed to elucidate the exact mechanisms and develop targeted therapies for this condition.
Sources and full results
Most relevant research papers on this topic